Physician profile
Kay Elder
NPI 1154888501
$1,645.10
in general payments reported to CMS, 2019-2025
18 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $378 · 2022: $514 · 2023: $220 · 2024: $215 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $678.24 | 2021-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $259.69 | 2022-2025 | Airsupra, Breztri |
| Neurocrine Biosciences, INC. | $126.13 | 2022-2023 | Ingrezza |
| Novo Nordisk INC | $119.32 | 2022 | |
| Lilly USA, LLC | $94.66 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $71.07 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $68.38 | 2023-2025 | |
| Cranial Technologies, INC | $33.13 | 2022-2024 | Doc Band |
| Teva Pharmaceuticals USA, INC. | $27.50 | 2025 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $26.31 | 2022 | |
| Boston Scientific Corporation | $21.61 | 2025 | Wavewriter Alpha Prime 16 |
| Regeneron Healthcare Solutions, INC. | $20.96 | 2024 | Evkeeza |
| Sanofi Pasteur INC. | $18.81 | 2023 | |
| Cipher Pharmaceuticals US LLC | $18.45 | 2025 | Spinosad, Natroba |
| Amgen INC. | $16.27 | 2024 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.00 | 2024 | Interstim |
| Novartis Pharmaceuticals Corporation | $14.49 | 2023 | |
| Shield Therapeutics INC | $14.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.